These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 21031436)

  • 1. Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells.
    Liu X; Choi RY; Jawad SM; Arnold JT
    Prostate; 2011 May; 71(7):766-77. PubMed ID: 21031436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway.
    Lee SO; Lou W; Hou M; Onate SA; Gao AC
    Oncogene; 2003 Sep; 22(39):7981-8. PubMed ID: 12970746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSA regulates androgen receptor expression in prostate cancer cells.
    Saxena P; Trerotola M; Wang T; Li J; Sayeed A; Vanoudenhove J; Adams DS; Fitzgerald TJ; Altieri DC; Languino LR
    Prostate; 2012 May; 72(7):769-76. PubMed ID: 21956655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-catenin is involved in insulin-like growth factor 1-mediated transactivation of the androgen receptor.
    Verras M; Sun Z
    Mol Endocrinol; 2005 Feb; 19(2):391-8. PubMed ID: 15514031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells.
    Liu J; Youn H; Yang J; Du N; Liu J; Liu H; Li B
    Prostate; 2011 Sep; 71(12):1276-86. PubMed ID: 21308712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
    Culig Z; Hobisch A; Cronauer MV; Radmayr C; Trapman J; Hittmair A; Bartsch G; Klocker H
    Cancer Res; 1994 Oct; 54(20):5474-8. PubMed ID: 7522959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells.
    Shankar E; Song K; Corum SL; Bane KL; Wang H; Kao HY; Danielpour D
    J Biol Chem; 2016 Mar; 291(11):5512-5526. PubMed ID: 26786102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen activates β-catenin signaling in bladder cancer cells.
    Li Y; Zheng Y; Izumi K; Ishiguro H; Ye B; Li F; Miyamoto H
    Endocr Relat Cancer; 2013 Jun; 20(3):293-304. PubMed ID: 23447569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway.
    Deep G; Oberlies NH; Kroll DJ; Agarwal R
    Oncogene; 2008 Jun; 27(28):3986-98. PubMed ID: 18332867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells.
    Tsui KH; Chang YL; Feng TH; Hou CP; Lin YH; Yang PS; Lee BW; Juang HH
    Prostate; 2018 Mar; 78(4):242-249. PubMed ID: 29164633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population.
    Heer R; Robson CN; Shenton BK; Leung HY
    J Cell Physiol; 2007 Sep; 212(3):572-8. PubMed ID: 17541959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human prostate stromal cells stimulate increased PSA production in DHEA-treated prostate cancer epithelial cells.
    Arnold JT; Gray NE; Jacobowitz K; Viswanathan L; Cheung PW; McFann KK; Le H; Blackman MR
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):240-6. PubMed ID: 18621129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis.
    Chesire DR; Ewing CM; Gage WR; Isaacs WB
    Oncogene; 2002 Apr; 21(17):2679-94. PubMed ID: 11965541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth.
    Yan J; Xie B; Capodice JL; Katz AE
    Prostate; 2012 Feb; 72(3):244-52. PubMed ID: 21656835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
    Dulinska-Litewka J; McCubrey JA; Laidler P
    Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP).
    Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J
    Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor.
    Kasina S; Macoska JA
    Mol Cell Endocrinol; 2012 Apr; 351(2):249-63. PubMed ID: 22245379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer.
    Clark EL; Hadjimichael C; Temperley R; Barnard A; Fuller-Pace FV; Robson CN
    PLoS One; 2013; 8(1):e54150. PubMed ID: 23349811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
    Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
    Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of androgen receptor function by IGF-1 signaling implications in the mechanism of refractory prostate carcinoma.
    Yanase T; Fan W
    Vitam Horm; 2009; 80():649-66. PubMed ID: 19251054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.